Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Mint Medical Clinic vs Spry

Mint Medical Clinic
Graded #433

Lower grade

vs+1.0999999999999943
Spry
Graded #408

Higher grade

The verdict

Spry takes it — 56.8/100 to 55.7/100, but only just.

Spry grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Spry is a weight-loss and anti-aging telehealth platform pairing compounded semaglutide ($199/mo) and tirzepatide ($299/mo) with three longevity peptides — BPC-157, NAD+, and sermorelin ($249–$299/mo). Mint Medical Clinic is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueSpry +12
42
54
Dose & formulationEven
64
64
Clinical oversightMint Medical Clinic +14
69
55
Labs & monitoringMint Medical Clinic +1
53
52
FulfillmentSpry +9
52
61
Contract termsEven
55
55
Mint Medical Clinic · left barSpry · right bar

The numbers

MetricMint Medical ClinicSpry
WeighScore55.7/10056.8/100
GradeCC
Scorecard rank#433#408
Semaglutide$299/mo (compounded)$199/mo (starting dose, compounded)
Tirzepatide$299/mo (compounded)$299/mo (starting dose, compounded)
Coverage1 stateCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Mint Medical Clinic

Graded #433 · C

Strengths

  • Hybrid model with an in-person consultation option for patients who prefer physical care
  • Parent practice disclosed (Balance Medical Clinic)
  • Physical Utah clinic addresses listed on the homepage
  • $299/mo flat starting price, competitive with national DTC providers
  • Broader scope (sexual health, hormones) may suit patients wanting integrated care

Where it loses points

  • Utah only for in-person; telehealth states served not disclosed
  • Pharmacy partner not disclosed
  • LegitScript certification not mentioned
  • 503A vs 503B compounding designation not disclosed
  • No named medical director on the homepage
Spry

Graded #408 · C

Strengths

  • Three named co-founders disclosed (Gabriel Mullins, Sara Yoder, Tyler Bowman) — better-than-average transparency
  • Pricing shown on the homepage ($199 semaglutide / $299 tirzepatide / $249–$299 peptides) — no full sign-up wall
  • Broader range (2 GLP-1s plus 3 anti-aging peptides) appeals to longevity buyers
  • No contracts or commitment required
  • LegitScript Certified with a public verification link

Where it loses points

  • Displays an "FDA Approved" badge though compounded GLP-1s are not FDA-approved finished drugs — potentially misleading
  • Intake reviewed by a nurse practitioner, not an MD
  • States served not disclosed publicly
  • Pharmacy partner not named, and 503A vs 503B designation not specified
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard